|
⚲
|
| Critical Biologics Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001387704 |
| Sale | 2009-07-24 ($1.6 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6175206662 |
| Address | One Mifflin Place Cambridge, 02138 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| James Fordyce | |
| Gerald Chan | |
| Thomas Stossel | |
| Ashleigh Palmer | |
| Scott Coleridge |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ASF VIII B LP
✚
|
0.0 | |
|
Atkinson Heather
✚
|
0.0 | |
|
Augment Collective, LLC
✚
|
0.0 | |
|
Axion BioSystems, Inc.
✚
|
0.0 | |
|
Baby Generation, Inc.
✚
|
0.0 | |
|
BBH Real Estate Income Fund III, L.P.
✚
|
0.0 | |
|
BD Victoria Flats LLC
✚
|
0.0 | |
|
Belden Inc
✚
|
0.0 | |
|
Biggs John G.
✚
|
0.0 | |
|
Ares European Credit Investments I C LP
✚
|
0.0 |